Open AccessUse of the Monoclonal Antibody Regdanvimab to Treat Patients Hospitalized with COVID-19: Real-World Data during the Delta Variant Predominance
Author(s) -
Yee Gyung Kwak,
Je Eun Song,
Jieun Kang,
Jiyeon Kang,
Hyung Koo Kang,
HyeonKyoung Koo,
Hye Kyeong Park,
Sang Bong Choi,
Hyuk Pyo Lee,
Myung Jin Lee,
Baek-Nam Kim
Publication year - 2022
Publication title -
infection and chemotherapy
Language(s) - English
Resource type - Journals
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2022.0103
Subject(s) - medicine , covid-19 , monoclonal antibody , disease , antibody , coronavirus , respiratory system , immunology , virology , infectious disease (medical specialty) , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom